Skip to main content
. 2022 Jul 17;77(1):20–32. doi: 10.1002/hep.32599

TABLE 1. Summary of pruritusa in a noncirrhotic NASH Phase 2 study.

CILO 100 mg (n = 56) CILO 30 mg (n = 56) PBO (n = 28)
Grade 1, n (%) 8 (14) 10 (18) 5 (18)
Grade 2, n (%) 7 (13) 1 (2) 0
Grade 3, n (%) 1 (2) 0 0
Any Grade, n (%) 16 (29) 11 (20) 5 (18)

Abbreviations: CILO, cilofexor; PBO, placebo.

a

Pruritus and pruritus generalized in the adverse event list.